<DOC>
	<DOC>NCT00860119</DOC>
	<brief_summary>This study tests the assumption that the bioavailability of alprazolam from a new sublingual formulation is the same as that from a standard orally administered tablet.</brief_summary>
	<brief_title>Bioequivalence of Alprazolam Sublingual vs Oral Tablets</brief_title>
	<detailed_description />
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Healthy male or female subjects BMI 17.5 30.5 Must provide informed consent Clinically significant disease Narrow angle glaucoma Positive drug screen</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Bioequivalence, Pharmacokinetics, Alprazolam, Sublingual</keyword>
</DOC>